Changes in the Supervisory Board of HELIX IMMUNO-ONCOLOGY S.A.

On January 29, 2021, the Extraordinary Shareholders’ Meeting of Helix Immuno-Oncology S.A. passed a resolution on changes in the composition of the Company’s Supervisory Board, appointing Mr. Piotr Kamiński to the Company’s Supervisory Board. Due to the resignation of Supervisory Board Member, Mr. Heman Chao, the Company’s Supervisory Board functions in the following composition:

• Professor Sławomir Majewski – Chairman of the Supervisory Board
• Mr Andreas Kandziora – Member of the Supervisory Board
• Mr Piotr Kamiński – Member of the Supervisory Board